How it works?
Senza categoria

Expanding the Spectrum of Lesions with COL1A1:: PDGFB Fusion: three unusual myofibroblastic lesions


et al. Gerardo Cazzato

USCAP

DESCRIPTION

USCAP 2025 Scientific PosterDownload

Back



RELATED ARTICLES

Demonstrating the interference of tissue processing in the evaluation ...

Ana Caramelo, Antonio Polonia, Joao Vale, Monica Curado, Sofia Campelos, Vanessa Nascimento, Mariana...


Pathology - Research and Practice
Donatello Series

The immunohistochemical (IHC) expression of PD-L1 in cancer models is used as a predictive biomarker of response to immunotherapy. We […]...



Preclinical model of advanced prostate cancer...

et al. Rydell Alvarez-Arzola...


Cell Communication and Signaling
H&E - Ottix

Androgen deprivation therapy (ADT) is a standard therapy for prostate cancer (PCa). Though disseminated disease is initially sensitive to ADT, […]...



Diapath Lab Talks | Privacy Policy